August 19, 2026
Crypto led the close with ETH +19.3% and XRP +11.8%, while equities finished mixed—COIN +9.6%, BMNR +10.7%, and HIMS +13.5% soared, but AMD -3.7% and NVDA -1.0% stumbled despite bullish takes. The defining narrative: biotech momentum (Moderna/Merck cancer vaccine trial success), paired with macro headwinds (U.S. debt hitting $40T) and AI infrastructure shifts (Marvell benefiting from Google chip deals). Watch overnight for Fed policy chatter and whether crypto strength holds through tomorrow's open.
Get this written around your own watchlist, by 7am — free, no card. Start free
The Call · Market moves · While you were away · Why it's moving · The conversation · Opportunities
| Ticker | Price | Change |
|---|---|---|
| TSLA | 351.12 | ▲ +4.23% |
| QQQ | 716.08 | ▼ -0.20% |
| NVDA | 217.56 | ▼ -0.99% |
| AMD | 466.42 | ▼ -3.71% |
| HIMS | 31.09 | ▲ +13.51% |
| SOFI | 18.42 | ▲ +4.30% |
| LULU | 119.45 | ▲ +0.37% |
| AAPL | 316.83 | ▲ +2.19% |
| COIN | 160.20 | ▲ +9.55% |
| FUBO | 10.33 | ▲ +3.40% |
| ELF | 99.65 | ▲ +7.72% |
| SPCX | 139.65 | ▼ -2.57% |
| ADBE | 272.47 | ▲ +3.55% |
| SPY | 769.06 | ▲ +0.21% |
| CRM | 206.09 | ▲ +5.07% |
| BMNR | 20.24 | ▲ +10.72% |
| PLTR | 175.19 | ▲ +2.13% |
| MU | 937.11 | ▼ -0.39% |
| TTD | 13.54 | ▲ +0.89% |
| HOOD | 95.77 | ▲ +4.63% |
| BTC | 69,678.99 | ▲ +7.82% |
| ETH | 2,283.72 | ▲ +19.34% |
| XRP | 1.12 | ▲ +11.81% |
- ETH +19.3%, XRP +11.8% lead crypto surge
- HIMS +13.5%, COIN +9.6% outperform equities
- AMD -3.7%, NVDA -1.0% diverge on AI
- Moderna/Merck cancer vaccine trial fuels biotech
- U.S. debt passes $40T; Fed pressure mounting
- Marvell pops on Google chip partnership news
- HIMS — Telehealth beneficiary of retail rotation away from mega-cap tech into healthcare and fintech growth plays.
- COIN — Crypto strength (BTC +7.8%, ETH +19.3%, XRP +11.8%) lifts exchange valuations.
- BMNR — Likely beneficiary of defense/infrastructure narrative or AI tooling momentum; no headline specificity prevents full confirmation.
- ETH — Strong institutional inflow; likely tied to broader crypto recovery or macro sentiment shift.
Biotech vaccine breakthroughs reshaping growth allocation · Macro debt ceiling vs. Fed policy pivot · Chip supply chain: Google deals shift winners · Crypto liquidity and retail sentiment recovery · AI infrastructure (edge, cloud) consolidation pressure — hottest: Biotech and fintech rotation as growth investors flee mega-cap semiconductor weakness
- Eli Lilly/Amplitude RNA vaccine deal: biotech API/integration surface widening
- QNB Nasdaq listing signals fintech pipeline capital returning post-uncertainty
- Marvell/Google chip partnership: watch for edge AI accelerator ecosystem plays
- Hermes Bot release: agent commerce UX benchmarking opportunity for builders
- Crypto rebound: stablecoin rails and settlement infrastructure under-served still
Get this brief with your own watchlist, alerts, and AI analyst
DailyHub writes it three times a day around the stocks, crypto, and topics you actually follow — with live markets, smart alerts, and an AI research desk.
Sign up freeFree. No credit card.